FDA Warns of Increased Risk of Death With CLL, Lymphoma Drug ...Middle East

Medscape - News
The FDA also noted a serious risk of side effects with duvelisib. The agency's warning letter closely follows the withdrawal of another PI3 kinase inhibitor. News Alerts

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Warns of Increased Risk of Death With CLL, Lymphoma Drug )

Also on site :